Cargando…

Pulmonary embolism in patients with COVID-19 and its treatment based on low-molecular-weight heparin

Detalles Bibliográficos
Autores principales:	Hosseini, Amin, Bahramnezhad, Fatemeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Paulista de Medicina - APM 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673830/ https://www.ncbi.nlm.nih.gov/pubmed/32813845 http://dx.doi.org/10.1590/1516-3180.2020.0221.R2.22072020

Ejemplares similares

Hemodialysis in COVID-19 Patients: Yes or No? A Commentary
por: Hosseini, Amin, et al.
Publicado: (2020)

Spontaneous and Severe Haematomas in Patients with COVID-19 on Low- Molecular-Weight Heparin for Paroxysmal Atrial Fibrillation
por: Mazzitelli, Maria, et al.
Publicado: (2020)

Direct oral anticoagulants vs. low-molecular-weight heparin for pulmonary embolism in patients with glioblastoma
por: Dubinski, Daniel, et al.
Publicado: (2021)

Sustained drug-related reaction with eosinophilia and systemic symptoms (DRESS) triggered by low molecular weight heparins in COVID-19: management and precision diagnosis
por: Minenna, Elena, et al.
Publicado: (2021)

Low molecular weight heparins in COVID-19 patients: beware of augmented renal clearance!
por: Tomasa-Irriguible, Teresa Maria, et al.
Publicado: (2020)

False-positive results of lupus anticoagulant tests should be kept in mind in pregnant patients receiving low molecular weight heparin
por: Beyazit, Fatma, et al.
Publicado: (2021)

The role of vascular surgeons in the treatment of COVID-19-associated pulmonary embolism
por: Patelis, Nikolaos, et al.
Publicado: (2020)

Pulmonary Embolism, Pulmonary Microvascular Thrombosis, or Both in COVID-19?
por: Páramo, José A.
Publicado: (2020)

Acute pulmonary embolism in COVID-19 disease
por: Kalemci, Serdar, et al.
Publicado: (2020)

2020: The Heroes with the Lamp and Corona-Virus Pandemic
por: Bahramnezhad, Fatemeh, et al.
Publicado: (2021)

Bilateral Pulmonary Embolism and Impending Paradoxical Embolism After COVID-19 Vaccination
por: Grant, Stuart W., et al.
Publicado: (2023)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
por: Perna, Alessandra F., et al.
Publicado: (2020)

Acute pulmonary embolism: An unseen villain in COVID-19
por: Agstam, Sourabh, et al.
Publicado: (2020)

Characteristics and outcomes of COVID-19-associated pulmonary embolism
por: Sedhom, Ramy, et al.
Publicado: (2023)

Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study
Publicado: (2021)

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
por: Trunfio, Mattia, et al.
Publicado: (2020)

Pulmonary embolism detected by CT pulmonary angiography in hospitalized COVID-19 patients
por: Bunel, V., et al.
Publicado: (2021)

Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment
por: Sottilotta, Gianluca, et al.
Publicado: (2021)

Use of low-molecular-weight heparin in COVID-19 patients
por: Kow, Chia Siang, et al.
Publicado: (2020)

Low molecular weight heparin in COVID-19: benefits and concerns
por: Makarem, Adham, et al.
Publicado: (2023)

Does COVID-19 vaccination protect against pulmonary embolism?
por: Tantillo, Simona, et al.
Publicado: (2023)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
por: Song, Yijun, et al.
Publicado: (2023)

Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients
por: Volteas, Panagiotis, et al.
Publicado: (2022)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

Occurrence of Acute Pulmonary Embolism in COVID-19—A case series
por: Bavaro, Davide Fiore, et al.
Publicado: (2020)

Potential of heparin and nafamostat combination therapy for COVID‐19
por: Asakura, Hidesaku, et al.
Publicado: (2020)

Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
por: Taleja, Hitesh, et al.
Publicado: (2021)

Heparin/low molecular weight heparins: Thrombocytopenia: 7 case reports
Publicado: (2021)

Low molecular weight heparin and 28-day mortality among patients with coronavirus disease 2019: A cohort study in the early epidemic era
por: Qin, Wei, et al.
Publicado: (2021)

Pulmonary embolism among critically ill patients with ARDS due to COVID-19
por: Soumagne, T., et al.
Publicado: (2020)

Pulmonary embolism and acro-ischemia in a lung cancer patient with COVID-19
por: González del Portillo, Elisabet, et al.
Publicado: (2020)

Fibrinolysis in COVID-19 patients with hemodynamic unstable acute pulmonary embolism: yes or no?
por: Roncon, Loris, et al.
Publicado: (2020)

Characteristics and predictors of pulmonary embolism in patients admitted for COVID-19 with respiratory failure
por: Fraccalini, Thomas, et al.
Publicado: (2022)

Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
por: Shute, Janis Kay
Publicado: (2023)

Arterial indications for the low molecular weight heparins
por: Ageno, Walter, et al.
Publicado: (2001)

The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
por: May, Jori E., et al.
Publicado: (2020)

Differentiating biochemical from clinical heparin resistance in COVID-19
por: Lisman, Ton, et al.
Publicado: (2020)

Heparin-induced hyponatremia in COVID-19: A latent culprit!
por: Panda, Rajesh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i0sfupe6rolv6nm1tusuuo0k72